Ludwig G. Strauss
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Application of F-18-sodium fluoride (NaF) dynamic PET-CT (dPET-CT) for defect healing: a comparison of biomaterials in an experimental osteoporotic rat model.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 16, 2014
Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.
Journal: Clinical laboratory
Published: October 09, 2014
Correlation of serum proteomics patterns of sCD200 (OX-2), sApo-2L (sTRAIL), vitamin-D and homocysteine to quantitative FDG-PET/CT findings in newly diagnosed non-small cell lung cancer.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: December 18, 2013
Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 23, 2013
Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.
Journal: Expert opinion on biological therapy
Published: July 26, 2013
A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels.
Journal: Clinical laboratory
Published: July 20, 2013
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up.
Journal: Immunopharmacology and immunotoxicology
Published: July 12, 2013
Dynamic PET with (18)F-Deoxyglucose (FDG) and quantitative assessment with a two-tissue compartment model reflect the activity of glucose transporters and hexokinases in patients with colorectal tumors.
Journal: American journal of nuclear medicine and molecular imaging
Published: July 05, 2013
Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib.
Journal: BioMed research international
Published: March 11, 2013
Response of calcitonin levels due to positron emission tomography with (18)F-FDG.
Journal: Hellenic journal of nuclear medicine
Published: December 11, 2012
Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 21, 2012
Last Updated: 09/26/2026